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The completion of whole genome sequencing projects has led to a rapid increase in the availability of 
genetic information. In the field of transcriptomics, the emergence of microarray-based technologies and 
the design of DNA biochips allow high-throughput studies of RNA expression in cell and tissue at a 
given moment. It has emerged as one of the most important technology in the field of molecular biology 
and transcriptomics. Arrays of oligonucleotide or DNA sequences are being used for genome-wide 
genotyping and expression profiling, and several potential clinical applications have begun to emerge as 
our understanding of these techniques and the data they generate improves. From its emergence to 
date, several database, software and technology updates have been developed in the field of 
microarray technology. This paper reviews basics and updates of each microarray technology and 
serves to introduce newly compiled resources that will provide specialist information in this area.  
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INTRODUCTION 
 
The completion of whole genome sequencing 
projects has led to a rapid increase in the 
availability of genetic information. In the field 
of transcriptomics, the emergence of 
microarray-based technologies and the 
design of DNA biochips allow high-throughput 
studies of RNA expression in cell and tissue 
at a given moment [1]. Today, microarray 
technology is one of the popular tools in 
molecular biology with its main advantage 
being that, unlike other traditional methods, it 
is not limited to investigating ‘one gene at a 
time’ [2].  
 
In this review, we explain some of the 
fundamentals and recent updates on each 
microarray technology step-by-step. As it will 
be overwhelming to discuss all the updates of 
microarrays since its emergence, we have 
focused on the updates of the past few years. 
We intend also to expound on current 
knowledge of recent databases, data analysis 
software and some of the companies in the 
field of microarrays. We hope that an 
understanding of some of the fundamentals, 
recent updates and commercial technologies 
in microarrays will afford the beginner useful 




Microarray is a technology which allows 
quantitative, simultaneous monitoring and 
expression of thousands of genes [3]. The 
basic principle behind microarray is the base 
complementarity, i.e., the base pair ‘A’ is 
complementary to ‘T’ and ‘C’ is 
complementary to ‘G’. In a microarray, many
  
thousands of spots are placed on a 
rectangular grid with each spot
 
containing a 
large number of pieces of DNA from a 
particular
 
gene. When the sample of interest 
contains many copies of mRNA,
 
many 
bindings will occur, indicating that the gene 
from the transcribed mRNA is highly 
expressed. The quantity of
 
hybridization can 
be determined because each copy of mRNA 
is
 
labeled in the experiment with a fluorescent 
or radioactive
 
tag and a brighter signal is 
detected when more copies bind [4]. In 
general, all microarray assays contain five 
discrete experimental steps – biological 
query, sample preparation, biochemical 
reaction, detection, data visualization and 
modeling [5]. According to Yuk Fai leung et al 
[6], a typical microarray experiment involves 
sample extraction, fluorescent labeling, co-
hybridization, scanning and finally statistical 
analysis. Microarray technologies can be 
broadly categorized into DNA microarrays 




DNA microarrays provide a simple and 
natural vehicle for exploring the genome in a 
way that is both systematic and 
comprehensive. The power and universality 
of DNA microarrays as experimental tools 
derives from the exquisite specificity and 
affinity of complementary base-pairing [7]. 
DNA microarrays are of oligonucleotide 




Oligonucleotide arrays or DNA chips are 
miniature parallel analytical devices 
containing libraries of oligonucleotides 
robotically spotted (printed) or synthesized in 
situ on solid supports (glass, coated glass, 
silicon or plastic) in a such way that the 
identity of each oligonucleotide is defined by 
its location [8]. Oligonucleotide arrays contain 
short fragments of DNA (25
 
base pairs). One 
of the commercially available oligonucleotide 
microarrays are the Gene Chips developed 
by firms such as Affymetrix. Ten to hundred 
thousands of different oligonucleotide probes 
are synthesized on each array. Traditionally, 
Affymetrix GeneChip Arrays are 
manufactured as a single array caged in a 
sealed cartridge with glass as a substrate. 
 
The oligonucleotide technology pioneered by 
Affymetrix GeneChips differs from cDNA 
microarray in two important respects [9]. 
First, the probes are a set of 20-25 short 
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oligonucleotides that are specific for each 
gene or exon, along with the related set with 
single base mismatches incorporated at the 
middle position of each oligonucleotide. 
These are synthesized in situ on each silicon 
chip using genome sequence information to 
guide photolithographic deposition. Second, 
the arrays are hybridized to a single 
biotinylated amplified RNA sample, and the 
intensity measure for each gene is computed 
by an algorithm that messages the difference 
between the match and mismatch 
measurements, and averages over each 
oligonucleotide. Key difference between gene 
chips and a cDNA microarray is the way 
genes are represented on the arrays. In in 
situ photolithographic synthesis method used 
by Affymetrix gene chip probe arrays, the 
quality of chips produced depends critically 
on the efficiency of photo-deprotection [10].  
 
There are many other advantages to 
oligonucleotide-based microarrays. The 
quality and reproducibility of printed 
oligonucleotide arrays (“print format”) are 
superior [11]. Although there is a large initial 
capital outlay to purchase large sets of 
oligonucleotides, the printed arrays are 
inexpensive on a unit basis. Furthermore, 
long oligonucleotide probes can be 
synthesized directly on an array surface 
(photo printed arrays). In either case, whether 
printed or photo printed, the composition of 
the array can be absolutely specified and 
hence is completely reproducible by others. A 
limitation of oligonucleotide arrays is the 
requirement of relatively large amounts of 
biological starting materials for gene 
expression analysis [12]. GE Healthcare, 
Ocimum Biosolutions, and Agilent are some 
of the other companies which provide 







long fragments of DNA 
(from 100 to thousands of base pairs). cDNA 
arrays are created by robotically
 
spotting 
individual samples of purified cDNA clones 
onto a solid support (glass
 
slide or 
membrane). Some of the basic principles 
behind preparation of cDNA arrays includes: 
i) selection of the targets to be printed on the 
array directly from databases such as 
GenBank, dbESt, and UniGene or randomly 
from any library of interest; ii) arraying the 
selected cDNA targets onto the known 
location of coated glass microscope slide 
using a computer-controlled high speed 
robot; iii) fluorescently labeling the total RNA 
from both test and reference samples using 
dyes with a single round of reverse 
transcription; iv) pooling the florescent target 
for hybridization under stringent conditions; v) 
measuring the laser excited incorporated 
targets using a scanning confocal laser 
microscope; and v) finally, analyzing the 
images from scanner by importing into a 
software in which they are pseudo-colored 
and merged. Micro spotting, piezoelectric 
printing and photolithography (an ‘in situ’ 
fabrication technique developed by 
Affymetrix) are some of the techniques used 
for arraying cDNA. Invitrogen, Genome 
systems, Biodiscovery, Xeno, Affymetrix, 
Silicon genetics, Genetix, etc., are some of 
the companies which produce commercial 
arrayers. Open GMS 418 Array Scanner, 
GeneChip® Scanner 3000 System 
(Affymetrix), DNA Microarray Scanner 
(Agilent), Typhoon Variable Mode Imager 
(GE Healthcare), InnoScan 700( INNOPSIS), 
Axon GenePix4000ALMicroarray scanner 
(Molecular Devices), and PowerScanner 
(Tecan) are some of the commercial 
scanning devices which detect different levels 
of fluorescence between the spots on the 
microarray. Apart from applications of cDNA 
array in comparative genome analysis and 
functional genome analysis, recent 
applications include gene expression profiling 
of drug-resistant small cell lung cancer cells 
[13], characterization of osmotic stress-
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Though DNA microarray is very useful, it has 
several limitations. The expression levels of 
many genes are subject to significant post-
transcriptional regulation and many proteins 
are grossly affected by post-translational 
modification such as phosphorylation, 
glycosylation, acetylation, proteolysis etc. 
Obviously, a nucleic acid-based array is blind 
to such effects and for certain applications, 
the tedious sample preparation requirements 
of DNA microarrays make them impractical 
[15]. The solution for this is to analyze 
proteins rather than make inferences based 
on RNA levels directly which can be done 
through protein microarrays. Protein 
microarrays also known as protein chips are 
nothing but grids that contain small amounts 
of purified proteins in ahigh density. The 
proteins can be screened in a high-
throughput fashion for biochemical activity, 
protein–protein, protein–DNA, protein–RNA 
and protein–ligand interactions [16]. The 
common element for each type of microarray, 
whether it is tissue array or antibody array or 
protein arrays, is the immobilization of bait 
molecules on a substratum, either as a 
homogeneous or heterogeneous spot. Bait 
molecules may be aptamers, antibodies, cell 
lysates, phage or recombinant 
protein/peptide, a nucleic acid, or a tissue 
depending upon the type of microarray. The 
capture molecule may be a complex biologic 
mixture, such as serum or a cell lysate, an 
antibody or ligand [17]. The substratum can 
be glass slides, porous gel slides and 
microwells.  
 
Protein microarrays can be major categorized 
into three types [18]: analytical microarrays, 
functional microarrays, and reverse phase 
microarrays. Analytical microarrays are the 
ones in which biomolecular recognition 
molecules are immobilized on a 
heterogeneous matrix using micro printing or 
micro structuring process. Hapten and 
antibody microarrays are some of the most 
common analytical microarrays. Among the 
several subgroups of protein biochips such 
as peptide arrays, antibody arrays, cell based 
arrays, etc, antibody arrays are the widely 
used ones. In antibody microarrays, bait 
molecules are numerous individual antibodies 
(< 500 antibodies/array) which act as probes 
for the targeted protein analytes immobilized 
on a surface. This surface can be glass or 
ceramic base as in the case of CombiMatrix 
ElectraSense microarray.  
 
The main problems with antibody-mediated 
analytical protein microarrays are specificity, 
quantization and most of the antibodies 
cross-react with proteins other than the 
antigen of interest which leads to poor 
quantification. Clontech, Eurogentec, 
Labvision corporation, Arrayit, Sigma Life 
sciences, Abnova, etc, are some of the 
companies which prepare antibody arrays. 
Among these, Abnova is the largest 
manufacturer of antibody arrays with 41 
products. Current antibody microarray 
designs provide a unique tool for rapid, 
sensitive and selective profiling of crude, non-
fractionated proteomes, targeting upto 
hundreds of protein analytes in one 
experiment [19], e.g., Clontech’s “Ab 
Microarray 500” technology allows profiling of 
507 antibodies in a one-day experiment. In 
recent years, these antibody microarrays play 
a key role for specific detection of 
bioterrorism agents, as exemplified by ricin, 
cholera toxin (CT) and staphylococcal 
enterotoxin B (SEB) [20]. Some of the 
companies which prepare antibody arrays, 
along with their products, are listed in Table 
1.  
 
The second type of microarray is functional 
protein microarrays which are composed of 
arrays containing full-length functional 
proteins or protein domains. These spotted 
arrays are used to probe the function or 
binding properties of native proteins. 
Functional protein microarrays have been 
successfully applied to identify protein–
protein, protein–small molecule and protein–
DNA interactions to reveal or characterize 
enzymatic activities of proteins.  
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Table 1:  Summary of antibody microarray firms 
 
Firm Technology Comments  
Affymetrix Human Cytokine 
Antibody Array 
EXPANDED ver 3.0 
Facilitates, simultaneous detection of multiple human 
cytokines from a variety of sources, including cell lysates, 
conditioned media, patient sera, plasma and urine.  
Clontech Antibody Microarrays 
380 & 500 
Screens 380 or 507 antibodies in one day.  
Full Moon 
Biosystems 
Phospho Explorer S1 
Antibody Array 
Consists of 562 well-characterized phospho-specific 
antibodies, a subset of the Phospho Explorer Array 
(PEX100). It allows researchers to study and analyze 
hundreds of commonly examined proteins on a single 





Simultaneously profile the relative concentration of up to 
97 cytokines and related proteins. 
Hypromatrix Signal Transduction 
AntibodyArray 
Each Signal Transduction AntibodyArray contains 400 high 
quality antibodies against well-studied signaling proteins.  
MicroBioChips Plasmascan 380 Targets 380 native and low-abundant human serum 
proteins. 
RayBiotech, Inc RayBio Antibody Array 
G Series 
The principle of G series antibody arrays (glass slide 
based antibody arrays) is similar to membrane-based 
antibody arrays. Scientists can detect the expression of 
174 cytokines in a single experiment.  
R&D Systems Proteome Profiler 96 
Microplate-based 
Antibody Arrays 
Proteome Profiler 96 Antibody Arrays are 96-well 
microplate-based assays with up to 16 antibodies per well 





Contains 224 human antibodies to key cellular proteins 
with a special emphasis on cell signaling proteins. 
US Biomax, Inc Explorer Antibody 
Array 
Allows investigators to examine their samples against 656 
antibodies in a single experiment. 
 
The most promising task in functional 
microarray is fabrication of proteins in 
functional form or correctly folded form. 
Recent advances in fabrication of proteins 
include atmospheric pressure plasma (AP) 
treatment technique [21], surface-attached 
hydrogel microstructures in high concen-
trations [22], etc. The third type of microarray 
is reverse phase protein microarray (RPA). 
Unlike functional and antibody arrays, these 
RPA involves the immobilization of all 
proteins present in an individual tissue or cell 
population instead of a single probe. Some of 
the recent applications of RPA include 
understanding the pathobiology of complex 
disorders such as cancer, stroke and 
traumatic brain injury [23], identifying novel 
anti-invasion mechanisms and anti-metastatic 
activities, e.g., 3-(50-hydroxymethyl-20-furyl)-
1-benzyl-indazole [24], quantitative analysis 
of down regulated genes, disease 
progression and in discovering biomarkers. 
 
Detection strategies of Protein microarrays 
on the other hand can be of (1) label-free 
methods and (2) labeled probe methods. 
Label-free methods are mass spectrometry, 
surface plasmon resonance imaging (SPR) 
and atomic force microscopy. Labeled probe 
detection methods are of three types i.e., 
direct, indirect and sandwich. In direct 
detection strategies, a labeled probe directly 
binds to the target molecule immobilized on a 
substratum. Amplification strategies based on 
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avidin–biotin binding enhance the sensitivity 
of detection in direct detection methods. In, 
indirect detection strategies an immobilized 
probe is used for capturing labeled, specific 
molecules from a complex mixture of query 
molecules. In Sandwich assays, two distinct 
probes are used for detection of a capture 
molecule. The first probe is immobilized on 
the substratum and the molecule of interest 
binds to its cognate probe. A second, labeled 
probe detects the bound probe-capture 
molecule complex. 
 
MICROARRAY DATA ANALYSIS  
 
Microarray technologies generate huge 
amount of data. A typical microarray data set 
includes expression levels for thousands of 
genes across hundreds of conditions. 
Converting the data provided in a microarray 
dataset into meaningful biological information 
involves several steps including [25]: i) 
normalization ii) prediction of differentially 
expressed genes using comparison statistics 
iii) identification and partition of expression 
patterns based on up and down regulation, 
magnitude and clustering of genes iv) 
summarizing the identified gene expression 
patterns using gene annotation tools, and v) 
deriving the biological significance of 
summarized genes using ontology report or 
pathway report.  Precise microarray data 
analysis involves quality control, 
normalization, statistical analysis, clustering 
and classification. 
 
Quality control involves, background 
correction and filtering to include only positive 
values above the background. ERCC 
(External RNA Control Consortium), The 
Norwegian Microarray Consortiums (NMC) 
and MAQC (Microarray Quality Control) 
project are some of the groups which aim to 
provide quality control (QC) tools to the 
microarray community for avoiding 
procedural failures. Multicheck, LaserCheck, 
QC Pac 1, and Simpleaffy are some of the 
commercial software packages provided by 
companies such as Tecan Group Ltd and 
Affymetrix, and are used for quality control. 
Normalization or scaling involves conversion 
of raw data into normalized or scaled data. It 
is an important step for microarray data 
analysis to minimize biological and technical 
variations. Gene Expression Pattern Analysis 
Suite (GEPAS) and Ginkgo are some of the 
software used for normalization of microarray 
data. Statistical analysis or calculating 
differential expression involves controlling the 
false positives, selecting a significant cutoff, 
multiple testing correction, etc. Clustering, on 
the other hand, is nothing but, unsupervised 
grouping of similar profiles together based on 
a distance metric while supervised grouping 
is called classification. CAGED and DNA-chip 
analyzer are some of the software used for 
clustering analysis. Some of the software that 
are used at various stages of microarray data 
analysis are illustrated in the Figure 1 while a 
short description of these software is 




A huge amount of data obtained through 
microarray technologies analyzed as 
described above are maintained in two ways 
[47]: (a) using a software, usually installed 
locally, that allows storage, querying and 
analysis of data captured on-site, and (b) 
databases that act as repositories for publicly 
available data, in particular, published data. 
Three important elements to be considered 
for sharing microarray data are i) a data 
annotation
 
standard ii) a common data 
exchange format, and iii) public repositories
 
analogous to DDBJ/EMBL/GenBank. The 
common microarray data standard used is 
Minimum Information About a Microarray
 
Experiment (MIAME) and the standard data 
exchange format is Microarray Gene 
Expression Markup Language (MAGE-ML) 
which is an XML based data exchange format 
developed
 
by Microarray Gene Expression 
Data (MGED) Society and Object 
Management Group (OMG) [48]. In Table 3 
some of the recent database repositories and 
data management systems have been 
surmmarised as it would well be  beyond  the  
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Figure 1: Various software used in microarray data analysis 
 
 
Table 2: Summary of microarray data analysis software  
 
Category Software Comments References 
ArrayQuality-
Metrics 
Bioconductor package used for assessing the 
quality and identifying apparent outlier arrays.  
[26] 
Goober Software package available to help critical 




Lumi It is a bioconductor package especially 
designed to process the Illumina microarray 
data which includes data input, quality 
control, variance stabilization, normalization 
and gene annotation portions.  
[28] 





functions for thorough 
quality assessment of the data and 
automatically
 
generates warnings to notify the 
user of potential outliers,
 
low-quality chips, or 











Quality control and 
assessment 
QC Pac 1 
and QC Pac 
2 
Comprehensive quality control package for 
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Table 2: Summary of microarray data analysis software (contd)  
 
 
Category Software Comments References 
Gene ARMADA It is a suite which integrates all steps of 
microarray data analysis including automated 
data import, noise correction and filtering, 
normalization, statistical selection of 
differentially expressed genes, clustering, 
classification and annotation. 
[31] 
GeneTrailExpress Web based tool box which provide powerful 
normalization and statistical procedures.  
[32] 
 
µ-CS It is a cross-platform tool used for automatic 
normalization, summarization and annotation 
















Normalization of data) 
Consists of a collection of algorithms directed 
at the normalization and standardiz-ation of 
DNA microarray data.  
[34] 
BRB-ArrayTools  An integrated package for the visualization and 
statistical analysis of DNA microarray gene 
expression data.  
[35] 
 
Genespring GX Provides powerful, accessible statistical tools 
for fast visualization and analysis of 





It is a collection of Perl utilities developed for 
the statistical and bioinformatics analysis of 










Nexus Expression Statistical analysis software which provides 
functional annotation and enrichment analysis 
as well as gene set analysis in real time 
allowing the user to input custom lists of genes 





Simultaneously profile the relative 
concentration of up to 97 cytokines and related 
proteins.  
[39] 
AutoSOME It is a unsupervised multi dimensional 
clustering method used to identify clusters 
from large numerical datasets without prior 
knowledge of cluster number. 
[40] 
 
Clustering analysis of 




It is a web server application for clustering 















ConsensusCluster A stand-alone software tool for the analysis of 
high-dimensional single nucleotide 
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Table 2: Summary of microarray data analysis software (contd)  
 





It is a web-based workbench where user can 
conveniently compare the classification performances 









A tool to visualize cluster results and investigate 
additional properties of clusters using interactive 
neighborhood graphs. 
[44] 
SEURAT It is a software tool which provides interactive visualiza-
tion for the integrated analysis of high-dimensional gene 








VisHic It is a public web server for clustering and interpreting 
gene expression data. Performs the labor-intensive task 
of evaluating hundreds of redundant clusters in a rapid 
automated manner.  
[46] 
 
Table 3:  Summary of Microarray Databases  
 
Database Comment References 
aeGEPUCI aeGEPUCI is a publicly-accessible database and data-mining tool, that 
integrates microarray analyses of sex- and stage-specific gene 




ANEXdb (an integrated animal ANnotation and microarray EXpression 
database) is an open-source web application that supports integrated 
access of two databases that house microarray expression (ExpressDB) 
and EST annotation (AnnotDB) data. Currently supports storage and 
querying of Affymetrix-based expression data as well as retrieval of 
experiments in a form ready for NCBI-GEO submission. 
[50] 
GATExplorer GATExplorer (Genomic and Transcriptomic Explorer) is a database and 
web platform that integrates a gene loci browser with nucleotide level 











DB is a human curated microarray database designed for easy 
querying based on clinical information and for interactive retrieval of 
either raw or uniformly pre-processed data, along with a set of quality-
control metrics. The database contains more than 10,000 previously 
published Affymetrix GeneChip arrays, performed using human clinical 
specimens. 
[52] 
OligoArrayDb OligoArrayDb is a comprehensive database containing pangenomic 
oligonucleotide microarray probe sets designed for most of the 
sequenced genomes that are not covered by commercial catalog arrays. 
Contains more than 2.8 probes per gene in average for more than 600 
organisms, mostly archaea and bacteria strains available from public 
database. 
[53] 
PathEx PathEx main goal was to develop a novel concept to offer less exploited 
opportunities for the analysis of deposited microarray data. Deposited 
microarray data comes with description files. These metadata files 
contain some key information that can be used to link the microarray 
data to other biologically related information.  
[54] 
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scope of this article to review all the software 
and database repositories for microarray 
technologies, which have been thoroughly 




Microarrays are one of the excellent high-
throughput technologies in the field of 
genomics and proteomics. Over the past 
decade, these microarrays have emerged as 
outstanding tools in molecular biology. In the 
near future, these may satisfy the rising 
needs of the scientific community to relate 
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